Poseida Therapeutics Inc
(PSTX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2018 | 12-2017 | 12-2012 | 12-2011 | 12-2010 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -44,404 | N/A | -2,202 | -1,900 | 2,000 |
| Depreciation Amortization | 1,220 | N/A | 2,119 | 908 | 892 |
| Income taxes - deferred | -202 | N/A | N/A | N/A | N/A |
| Accounts receivable | N/A | N/A | -108 | -535 | 134 |
| Accounts payable and accrued liabilities | 1,004 | N/A | 1,691 | 203 | 1,563 |
| Other Working Capital | 718 | N/A | 1,918 | -2,924 | -6,549 |
| Other Operating Activity | 3,650 | 0 | -801 | 285 | -3,200 |
| Operating Cash Flow | $-38,014 | $N/A | $2,617 | $-3,964 | $-5,160 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,284 | N/A | -4,936 | -1,295 | -868 |
| Investing Cash Flow | $-1,284 | $N/A | $-4,936 | $-1,295 | $-868 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 10,000 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 15,204 | N/A | 3,970 | 7,488 | N/A |
| Common Stock Repurchased | N/A | N/A | -65 | -379 | N/A |
| Dividend Paid | N/A | N/A | -77 | -78 | -77 |
| Other Financing Activity | 28,864 | 0 | 0 | 0 | 4,331 |
| Financing Cash Flow | $54,068 | $N/A | $3,828 | $7,031 | $4,254 |
| Beginning Cash Position | 15,625 | N/A | 3,669 | 1,896 | 3,447 |
| End Cash Position | 30,395 | N/A | 5,177 | 3,669 | 1,896 |
| Net Cash Flow | $14,770 | $N/A | $1,509 | $1,773 | $-1,551 |
| Free Cash Flow | |||||
| Operating Cash Flow | -38,014 | N/A | 2,617 | -3,964 | -5,160 |
| Capital Expenditure | -1,284 | N/A | -4,936 | -1,295 | -868 |
| Free Cash Flow | -39,298 | 0 | -2,319 | -5,259 | -6,028 |